Bioinvent International Ab Is A Clinical Stage Biotechnology Company Based In Lundswedenit Focuses On Discovering And Developing Antibody Based Therapies For Cancer Treatmentutilizing Its Expertise In Immunology And Cancer Biology To Create Innovative Solutions The Company Employs Its Proprietary F I R S Ttechnology Platform To Identify Therapeutic Targets And Develop Antibodiesbioinvent S Product Pipeline Features Several Candidatesincluding Bi 1808Which Targets Solid Tumors And Is In Phase 1 2A Clinical Trialsand Bi 1206Aimed At Enhancing Treatments For Non Hodgkin Lymphomaother Notable Products Include Bi 1607Designed For Metastatic Melanomaand Bt 001An Oncolytic Virus Developed In Collaboration With Transgene Founded In 1997Bioinvent Has Approximately 114 Employees And Has Established Partnerships With Major Pharmaceutical Companiesincluding A Clinical Agreement With Astrazeneca For Bi 1206
